FDA — authorised 26 September 2017
- Application: NDA208791
- Marketing authorisation holder: B BRAUN MEDICAL
- Local brand name: CLOROTEKAL
- Indication: SOLUTION — INTRATHECAL
- Status: approved
🇺🇸 Chloroprocaine Injection [Clorotekal] in United States
FDA authorised Chloroprocaine Injection [Clorotekal] on 26 September 2017
Marketing authorisation
Other Anesthesia approved in United States
Frequently asked questions
Is Chloroprocaine Injection [Clorotekal] approved in United States?
Yes. FDA authorised it on 26 September 2017.
Who is the marketing authorisation holder for Chloroprocaine Injection [Clorotekal] in United States?
B BRAUN MEDICAL holds the US marketing authorisation.